SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-071469
Filing Date
2022-06-15
Accepted
2022-06-15 16:30:03
Documents
12
Period of Report
2022-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2218565d1_8k.htm   iXBRL 8-K 33248
  Complete submission text file 0001104659-22-071469.txt   206475

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fencf-20220614.xsd EX-101.SCH 3033
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20220614_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20220614_pre.xml EX-101.PRE 22594
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2218565d1_8k_htm.xml XML 3615
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 221018086
SIC: 2836 Biological Products, (No Diagnostic Substances)